Oscar Health, Inc. (NYSE:OSCR) Given Consensus Recommendation of “Hold” by Analysts

Oscar Health, Inc. (NYSE:OSCR) has been assigned an average recommendation of “Hold” from the twelve analysts that are presently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell recommendation, seven have given a hold recommendation, three have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $20.7778.

A number of brokerages have recently issued reports on OSCR. Robert W. Baird raised their price objective on Oscar Health from $15.00 to $19.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. UBS Group increased their target price on Oscar Health from $15.00 to $20.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Jefferies Financial Group upgraded Oscar Health from an “underperform” rating to a “hold” rating and raised their price target for the stock from $10.00 to $16.00 in a research report on Monday, April 20th. Weiss Ratings upgraded Oscar Health from a “sell (d)” rating to a “sell (d+)” rating in a research report on Friday, July 10th. Finally, Wolfe Research began coverage on Oscar Health in a research note on Tuesday, May 5th. They set a “peer perform” rating for the company.

Insider Activity at Oscar Health

In related news, insider Adam Mcananey sold 9,859 shares of the firm’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total value of $216,306.46. Following the sale, the insider directly owned 218,096 shares of the company’s stock, valued at $4,785,026.24. This trade represents a 4.32% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Mario Schlosser sold 147,500 shares of the business’s stock in a transaction dated Tuesday, June 23rd. The shares were sold at an average price of $29.38, for a total value of $4,333,550.00. Following the transaction, the director owned 1,360,866 shares in the company, valued at approximately $39,982,243.08. This represents a 9.78% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 3,662,466 shares of company stock valued at $105,145,815 in the last quarter. 22.64% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Oscar Health

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Wedge Capital Management L L P NC purchased a new stake in Oscar Health in the second quarter worth $32,855,000. Allied Private Wealth LLC purchased a new position in Oscar Health during the 2nd quarter valued at $125,000. FNY Investment Advisers LLC bought a new position in Oscar Health in the 2nd quarter worth $57,000. Assenagon Asset Management S.A. lifted its position in shares of Oscar Health by 1.6% in the 2nd quarter. Assenagon Asset Management S.A. now owns 1,247,992 shares of the company’s stock worth $35,593,000 after purchasing an additional 20,189 shares during the period. Finally, Fermata Advisors LLC purchased a new stake in shares of Oscar Health in the 2nd quarter worth about $205,000. Institutional investors own 75.70% of the company’s stock.

Oscar Health Trading Down 4.1%

Shares of OSCR opened at $29.50 on Thursday. Oscar Health has a 1-year low of $10.69 and a 1-year high of $33.10. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.11 and a quick ratio of 1.11. The company has a market capitalization of $8.89 billion, a P/E ratio of -50.00, a P/E/G ratio of 1.72 and a beta of 2.34. The firm’s 50 day simple moving average is $27.33 and its 200 day simple moving average is $19.31.

Oscar Health (NYSE:OSCR) last issued its earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.96. The business had revenue of $4.65 billion during the quarter, compared to analyst estimates of $4.90 billion. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.Oscar Health’s revenue for the quarter was up 52.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.92 earnings per share. Sell-side analysts forecast that Oscar Health will post 0.59 earnings per share for the current fiscal year.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.